Sclerosing extramedullary hematopoietic tumor in chronic myeloproliferative disorders

American Journal of Surgical Pathology

Volumn 24, Issue 1, 2000, Pages 51-55

  Remstein, Ellen D ^a   Kurtin, Paul J ^a   Nascimento, Antonio G ^a  

^a MAYO CLINIC   (United States)

Author keywords

Agnogenic myeloid metaplasia; Cytogenetics; Hematopoietic tumor; Megakaryocytes; Myelofibrosis; Myeloproliferative disorder

Indexed keywords

ADULT; AGED; ARTICLE; CASE REPORT; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; ERYTHROID PRECURSOR CELL; HEMATOPOIETIC SYSTEM TUMOR; HODGKIN DISEASE; HUMAN; LIPOSARCOMA; MALE; MEGAKARYOCYTE; MYELOLIPOMA; MYELOPROLIFERATIVE DISORDER; SCLEROSIS;

AGED; BIOPSY; BONE MARROW; CHRONIC DISEASE; DIAGNOSIS, DIFFERENTIAL; HEMATOPOIESIS, EXTRAMEDULLARY; HUMANS; MALE; MIDDLE AGED; MYELOFIBROSIS; MYELOID METAPLASIA; MYELOPROLIFERATIVE DISORDERS;

EID: 0033982119     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000478-200001000-00006     Document Type: Article

References (20)

1. Asakura S. Colby T. Agnogenic myeloid metaplasia with extra-medullary hematopoiesis and fibrosis in the lung. Chest 1994;105: 1866-8.
2. Beckman E, Oehrle J. Fibrous hematopoietic tumors arising in agnogenic myeloid metaplasia. Hum Pathol 1982;13:804-10.
3. Brooks J, Krugman D, Damjanov I. Myeloid metaplasia presenting as a breast mass. Am J Surg Pathol 1980;4:281-5.
4. Castro-Malaspina H, Rabellino E, Yen A, et al. Human megakaryocyte stimulation of proliferation of bone marrow fibroblasts. Blood 1981;57:781-7.
5. Dalley A, Smith J, Reilly J, Neil S. Investigation of calmodulin and basic fibroblast growth factor (bFGF) in idiopathic myelofibrosis. Evidence for a role of extracellular calmodulin in fibroblast proliferation. Br J Haematol 1996;93:856-62.
6. Demory J, Dupriez B, Fenaux P, et al. Cytogenetic studies and their prognostic significance in agnogenic myeloid metaplasia: a report of 47 cases. Blood 1988;72:855-9.
7. Dupriez B, Morel P, Demory JL, et al. Prognostic factors in agnogenic myeloid metaplasia: a report on 195 cases with a new scoring system. Blood 1996;88:1013-8.
8. Ignotz R, Massague J. Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J Biol Chem 1986;261:4337-45.
9. Kimura A, Katoh O, Hyodo H, et al. Transforming growth factor-beta regulates growth as well as collagen and fibronectin synthesis of human marrow fibroblasts. Br J Haematol 1989;72:486-91.
10. Kimura A, Katoh O, Kuramoto A. Effects of platelet derived growth factor, epidermal growth factor and transforming growth factor-beta on the growth of human marrow fibroblasts. Br J Haematol 1988;69:9-12.
11. Kurtin P, Dewald G, Shields D, Hanson C. Hematologic disorders associated with deletions of chromosome 20q. Am J Clin Pathol 1996;106:680-8.
12. Lucas D, Nascimento A, Sanjay B, Rock M. Well-differentiated liposarcoma. The Mayo Clinic experience with 58 cases. Am J Clin Pathol 1994;102:677-83.
13. Martyre M, LeBousse-Kerdiles M, Romquin N, et al. Elevated levels of basic fibroblast growth factor in megakaryocytes and platelets from patients with idiopathic myelofibrosis. Br J Haematol 1997;97:441-8.
14. Martyre M, Magdelenat H, Bryckaert M, et al. Increased intra-platelet levels of platelet-derived growth factor and transforming growth factor-beta in patients with myelofibrosis with myeloid metaplasia. Br J Haematol 1991;77:80-6.
15. Pearson C, Pearson D, Shibahara S, et al. Tenascin: cDNA cloning and induction by TGF-beta. EMBO J 1988;7:2977-82.
16. Reilly J, Brindley L, Kay M, et al. Bone marrow and serum connective tissue polypeptides in idiopathic myelofibrosis. Clin Lab Haematol 1995;17:35-9.
17. Reilly J. Snowden J, Spearing R, et al. Cytogenetic abnormalities and their prognostic significance in idiopathic myelofibrosis: a study of 106 cases. Br J Haematol 1997;98:96-102.
18. Roberts A, Sporn M, Assoian R, et al. Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci USA 1986;83:4167-71.
19. Terui T, Niitsu Y, Mahar K, et al. The production of transforming growth factor-beta in acute megakaryoblastic leukemia and its possible implications in myelofibrosis. Blood 1990;75:1540-8.
20. Weiss SW, Rao VK. Well-differentiated liposarcoma (atypical lipoma) of deep soft tissue of the extremities, retroperitoneum, and miscellaneous sites. Am J Surg Pathol 1992;16:1051-8.